Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1976 Jul;49(3):235–241.

Viral hepatitis, type B.

L F Barker
PMCID: PMC2595372  PMID: 822594

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Rubenstein D., Stott E. J. New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971 Dec 4;2(7736):1225–1227. doi: 10.1016/s0140-6736(71)90543-5. [DOI] [PubMed] [Google Scholar]
  2. Alter H. J., Holland P. V., Morrow A. G., Purcell R. H., Feinstone S. M., Moritsugu Y. Clinical and serological analysis of transfusion-associated hepatitis. Lancet. 1975 Nov 1;2(7940):838–841. doi: 10.1016/s0140-6736(75)90234-2. [DOI] [PubMed] [Google Scholar]
  3. Alter H. J., Holland P. V., Purcell R. H., Lander J. J., Feinstone S. M., Morrow A. G., Schmidt P. J. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med. 1972 Nov;77(5):691–699. doi: 10.7326/0003-4819-77-5-691. [DOI] [PubMed] [Google Scholar]
  4. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  5. Bancroft W. H., Mundon F. K., Russell P. K. Detection of additional antigenic determinants of hepatitis B antigen. J Immunol. 1972 Oct;109(4):842–848. [PubMed] [Google Scholar]
  6. Barker L. F., Maynard J. E., Purcell R. H., Hoofnagle J. H., Berquist K. R., London W. T., Gerety R. J., Krushak D. H. Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis. 1975 Oct;132(4):451–458. doi: 10.1093/infdis/132.4.451. [DOI] [PubMed] [Google Scholar]
  7. Barker L. F., Murray R. Aquisition of hepatitis-associated antigen. Clinical features in young adults. JAMA. 1971 Jun 21;216(12):1970–1976. [PubMed] [Google Scholar]
  8. Barker L. F., Peterson M. R., Murray R. Application of the microtiter complement fixation technique to studies of hepatitis associated antigen in human hepatitis. Vox Sang. 1970 Sep-Oct;19(3):211–216. doi: 10.1111/j.1423-0410.1970.tb01514.x. [DOI] [PubMed] [Google Scholar]
  9. Barker L. F., Peterson M. R., Shulman N. R., Murray R. Antibody responses in viral hepatitis, type B. JAMA. 1973 Feb 26;223(9):1005–1008. [PubMed] [Google Scholar]
  10. Blumberg B. S., Sutnick A. I., London W. T. Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med. 1968 Dec;44(12):1566–1586. [PMC free article] [PubMed] [Google Scholar]
  11. Bouvier G. L., Williams A. Serotypes of hepatitis B antigen (HBs Ag): the problem of "new" determinants, as exemplified by "t". Am J Med Sci. 1975 Jul-Aug;270(1):165–171. doi: 10.1097/00000441-197507000-00023. [DOI] [PubMed] [Google Scholar]
  12. Dane D. S., Cameron C. H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970 Apr 4;1(7649):695–698. doi: 10.1016/s0140-6736(70)90926-8. [DOI] [PubMed] [Google Scholar]
  13. Desmyter J., Bradburne A. F., Vermylen C., Daneels R., Boelaert J. Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients. Lancet. 1975 Aug 30;2(7931):376–377. [PubMed] [Google Scholar]
  14. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  15. Gerety R. J., Hoofnagle J. H., Markenson J. A., Barker L. F. Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children. J Pediatr. 1974 May;84(5):661–665. doi: 10.1016/s0022-3476(74)80006-5. [DOI] [PubMed] [Google Scholar]
  16. Gerety R. J., Hoofnagle J. H., Nortman D. F., Barker L. F. Hepatitis B surface antigen (HBS Ag) subtypes and indices of clinical disease. Gastroenterology. 1975 May;68(5 Pt 1):1253–1260. [PubMed] [Google Scholar]
  17. Gocke D. J. A prospective study of posttransfusion hepatitis. The role of Australia Antigen. JAMA. 1972 Feb 28;219(9):1165–1170. [PubMed] [Google Scholar]
  18. Gocke D. J., Greenberg H. B., Kavey N. B. Hepatitis antigen. Detection of infectious blood donors. Lancet. 1969 Aug 2;2(7614):248–249. doi: 10.1016/s0140-6736(69)90011-7. [DOI] [PubMed] [Google Scholar]
  19. Grady G. F., Lee V. A. Hepatitis B immune globulin--prevention of hepatitis from accidental exposure among medical personnel. N Engl J Med. 1975 Nov 20;293(21):1067–1070. doi: 10.1056/NEJM197511202932104. [DOI] [PubMed] [Google Scholar]
  20. Hilleman M. R., Buynak E. B., Roehm R. R., Tytell A. A., Bertland A. U., Lampson G. P. Purified and inactivated human hepatitis B vaccine: progress report. Am J Med Sci. 1975 Sep-Oct;270(2):401–404. doi: 10.1097/00000441-197509000-00025. [DOI] [PubMed] [Google Scholar]
  21. Hirschman S. Z., Vernace S. J., Schaffner F. D.N.A. polymerase in preparations containing Australia antigen. Lancet. 1971 May 29;1(7709):1099–1103. doi: 10.1016/s0140-6736(71)91839-3. [DOI] [PubMed] [Google Scholar]
  22. Hoofnagle J. H., Gerety R. J., Barker L. F. Antibody to hepatitis-B-virus core in man. Lancet. 1973 Oct 20;2(7834):869–873. doi: 10.1016/s0140-6736(73)92004-7. [DOI] [PubMed] [Google Scholar]
  23. Hoofnagle J. H., Gerety R. J., Ni L. Y., Barker L. F. Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med. 1974 Jun 13;290(24):1336–1340. doi: 10.1056/NEJM197406132902402. [DOI] [PubMed] [Google Scholar]
  24. Iwarson S., Kjellman H., Ahlmén J., Ljunggren C., Eriksson E., Selander D., Hermodsson S. Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report. Am J Med Sci. 1975 Sep-Oct;270(2):385–389. doi: 10.1097/00000441-197509000-00022. [DOI] [PubMed] [Google Scholar]
  25. Kaplan P. M., Greenman R. L., Gerin J. L., Purcell R. H., Robinson W. S. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973 Nov;12(5):995–1005. doi: 10.1128/jvi.12.5.995-1005.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kasper C. K., Kipnis S. A. Hepatitis and clotting-factor concentrates. JAMA. 1972 Jul 31;221(5):510–510. [PubMed] [Google Scholar]
  27. Kingdon H. S. Hepatitis after Konyne. Ann Intern Med. 1970 Oct;73(4):656–657. doi: 10.7326/0003-4819-73-4-656_2. [DOI] [PubMed] [Google Scholar]
  28. Krugman S., Giles J. P., Hammond J. Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin. JAMA. 1971 Dec 13;218(11):1665–1670. [PubMed] [Google Scholar]
  29. Krugman S., Giles J. P. Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. N Engl J Med. 1973 Apr 12;288(15):755–760. doi: 10.1056/NEJM197304122881503. [DOI] [PubMed] [Google Scholar]
  30. Lander H. J., Holland P. V., Alter H. J., Chanock R. M., Purcell R. H. Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. JAMA. 1972 May 22;220(8):1079–1082. doi: 10.1001/jama.220.8.1079. [DOI] [PubMed] [Google Scholar]
  31. London W. T., Di Figlia M., Sutnick A., Blumberg B. S. An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med. 1969 Sep 11;281(11):571–578. doi: 10.1056/NEJM196909112811101. [DOI] [PubMed] [Google Scholar]
  32. Magnius L. O., Espmark J. A. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol. 1972 Nov;109(5):1017–1021. [PubMed] [Google Scholar]
  33. Mosley J. W., Edwards V. M., Meihaus J. E., Redeker A. G. Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. Am J Epidemiol. 1972 Jun;95(6):529–535. [PubMed] [Google Scholar]
  34. Okochi K., Murakami S. Observations on Australia antigen in Japanese. Vox Sang. 1968;15(5):374–385. doi: 10.1111/j.1423-0410.1968.tb04078.x. [DOI] [PubMed] [Google Scholar]
  35. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Prince A. M., Brotman B., Grady G. F., Kuhns W. J., Hazzi C., Levine R. W., Millian S. J. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet. 1974 Aug 3;2(7875):241–246. doi: 10.1016/s0140-6736(74)91412-3. [DOI] [PubMed] [Google Scholar]
  37. Prince A. M., Szmuness W., Mann M. K., Vyas G. N., Grady G. F., Shapiro F. L., Suki W. N., Friedman E. A., Stenzel K. H. Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med. 1975 Nov 20;293(21):1063–1067. doi: 10.1056/NEJM197511202932103. [DOI] [PubMed] [Google Scholar]
  38. Purcell R. H., Gerin J. L. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci. 1975 Sep-Oct;270(2):395–399. [PubMed] [Google Scholar]
  39. Redeker A. G., Mosley J. W., Gocke D. J., McKee A. P., Pollack W. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med. 1975 Nov 20;293(21):1055–1059. doi: 10.1056/NEJM197511202932101. [DOI] [PubMed] [Google Scholar]
  40. Sandler S. G., Rath C. E., Ruder A. Prothrombin complex concentrates in acquired hypoprothrombinemia. Ann Intern Med. 1973 Oct;79(4):485–491. doi: 10.7326/0003-4819-79-4-485. [DOI] [PubMed] [Google Scholar]
  41. Schweitzer I. L., Dunn A. E., Peters R. L., Spears R. L. Viral hepatitis b in neonates and infants. Am J Med. 1973 Dec;55(6):762–771. doi: 10.1016/0002-9343(73)90257-x. [DOI] [PubMed] [Google Scholar]
  42. Seeff L. B., Wright E. C., Finkelstein J. D., Greenlee H. B., Hamilton J., Leevy C. M., Tamburro C. H., Vlahcevic Z., Zimmon D. S., Zimmerman H. J. Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study. Lancet. 1975 Nov 15;2(7942):939–941. doi: 10.1016/s0140-6736(75)90357-8. [DOI] [PubMed] [Google Scholar]
  43. Seeff L. B., Wright E. C., Zimmerman H. J., McCollum R. W. Va cooperative study of post-transfusion hepatitis, 1969-1974: incidence and characteristics of hepatitis and responsible risk factors. Am J Med Sci. 1975 Sep-Oct;270(2):355–362. doi: 10.1097/00000441-197509000-00018. [DOI] [PubMed] [Google Scholar]
  44. Soulier J. P., Blatix C., Courouce A. M., Benamon D., Amouch P., Drouet J. Prevention of virus B hepatitis (SH hepatitis). Am J Dis Child. 1972 Apr;123(4):429–434. doi: 10.1001/archpedi.1972.02110100161061. [DOI] [PubMed] [Google Scholar]
  45. Szmuness W., Harley E. J., Prince A. M. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci. 1975 Sep-Oct;270(2):293–304. doi: 10.1097/00000441-197509000-00009. [DOI] [PubMed] [Google Scholar]
  46. Villarejos V. M., Visoná K. A., Gutiérrez A., Rodríguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med. 1974 Dec 26;291(26):1375–1378. doi: 10.1056/NEJM197412262912602. [DOI] [PubMed] [Google Scholar]
  47. Walsh J. H., Purcell R. H., Morrow A. G., Chanock R. M., Schmidt P. J. Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. JAMA. 1970 Jan 12;211(2):261–265. doi: 10.1001/jama.211.2.261. [DOI] [PubMed] [Google Scholar]
  48. Wands J. R., Walker J. A., Davis T. T., Waterbury L. A., Owens A. H., Carpenter C. C. Hepatitis B in an oncology unit. N Engl J Med. 1974 Dec 26;291(26):1371–1375. doi: 10.1056/NEJM197412262912601. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES